Back to Annual Meeting

Back to Annual Meeting

Abstract #159417

• Slides (pdf) or Handout

Nicole Monastersky Maderas, MPH, Sharon Cohen Landau, MPH, Ingrid Dries-Daffner, MPH, and Belle Taylor-McGhee. Pharmacy Access Partnership, 614 Grand Avenue, Suite 324, Oakland, CA 94610, 510-272-0150, nmonastersky@phi.org

The Food and Drug Administration's (FDA) August 2006 decision to make Plan B emergency contraception (EC) available without a prescription for consumers 18 and older has dramatically changed the landscape for EC access nationwide. While consumers age 18 and over (with proof of age) can obtain Plan B over the counter (OTC) without a prescription, women under 18 still require a prescription to obtain EC. Men age 18 and over can also purchase Plan B OTC. This policy change has impacted the pharmacy community, and enhances pharmacists' role in providing EC services and information, among other reproductive health services. Pharmacy Access Partnership spearheaded a collaborative research effort to identify pharmacists' experiences supplying Plan B in the new OTC environment. Following the FDA Plan B decision, pharmacists and pharmacy technicians in all 50 states were invited to participate in an online survey to share experiences and perspectives on providing EC under the new FDA guidelines. The survey addressed pharmacists' attitudes toward providing EC to women, men, and teens; barriers to access; cost of Plan B; pharmacists' understanding of the EC mechanism of action; and pharmacists' interest in the pharmacy access model for EC and other types of hormonal contraception. Survey results inform recommendations to improve access and training efforts for pharmacists, pharmacy technicians and students, to explore interest in a third-class of drugs, and to help set the policy agenda to improve future access to EC.

Learning Objectives:

• 1. Understand pharmacists’ experiences providing EC in the new OTC environment
• 2. Identify strategies to promote pharmacists’ understanding of EC
• 3. Determine strategies to promote increased access to EC for women of all ages

Keywords: Contraception, Pharmacies

Presenting author's disclosure statement:

Any relevant financial relationships? No
Any institutionally-contracted trials related to this submission?

I agree to comply with the American Public Health Association Conflict of Interest and Commercial Support Guidelines, and to disclose to the participants any off-label or experimental uses of a commercial product or service discussed in my presentation.

• Slides (pdf) or Handout